Tuesday, December 1 | 2:20 p.m.- 2:30 p.m. | T6-SSCH05-6 | Room E451A
Low-dose, ultra-high resolution PCCT appears optimal for chest CT imaging in patients with or without suspected or known interstitial lung disease.
Why? Because the technique imparts less radiation than standard-of-care dose, standard-resolution PCCT (SD-SR-PCCT) of the chest, according to session presenter Ana-Lucia L. Guzman Botero, MD, a radiation oncologist in Plantation, FL, and colleagues.
"[We found that low-dose, ultrahigh-resolution PCCT] LD-UHR-PCCT can provide diagnostic confidence for evaluation of [interstitial lung disease]-related lung abnormalities at substantial radiation dose reduction compared to SD-SR-PCCT with up to 90% slice burden reduction with a 2 mm inter-slice interval compared to full-volume UHR-PCCT," they noted.
In this Tuesday afternoon session, Botero will share findings from a study she and her team conducted that included 120 LD-UHR-PCCT and 24 SD-SR-PCCT exams from 254 patients aged 55 years or older. Highlights include a 36% lower dose length product (DLP) when using the low-dose, ultra-high resolution PCCT protocol (59 mGy versus 93 mGy) and 90% fewer images needed (112 compared to 1,332 images in the standard protocol).
Attend this talk to find out more about how the findings could affect clinical practice.



